News for BIOS Stock
BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
Riverbed|Aternity Announces Appointment of New Board of Directors
BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
Back to Sitemap